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Streptococcus agalactiae, or Lancefield group B 
Streptococcus (GBS), is one of the most important 
causal agent of serious infections and neonatal 
sepsis (Schuchat, 1998; Schrag et al., 2002a; Freitas 
et al., 2006). Maternal streptococcal colonization 
is associated with increased risk of urinary tract 
infection and adverse pregnancy outcome,
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Abstract 
Streptococcus agalactiae (group B Streptococcus; GBS) is a significant cause of 
perinatal and neonatal infections worldwide. The aim of this study was to 
evaluate the prevalence of GBS colonization among pregnant women in Gaza 
strip. 
A total of 200 rectovaginal swabs collected from pregnant women from Al Shifa 
hospital were screened for GBS colonization. Standard microbiological methods 
according to the Centers for Disease Control and Prevention (CDC) 
recommendations were used to isolate and identify GBS. Selective and 
chromogenic culture in addition to PCR were employed for the detection of GBS. 
Antimicrobial susceptibility testing (AST) was performed according to CLSI 
guidelines.  
Out of 200 pregnant women, 42 (21%) were colonized by GBS. The sensitivity, 
specificity, positive predictive value and negative predictive value of PCR were 
54%, 88%, 76%, and 72%, respectively. Of the GBS isolates examined 76%, 57%, 
50%, 48% and 31% were susceptible to vancomycin, penicillin, erythromycin, 
tetracycline and clindamycin, respectively. There was no statistically significant 
association between GBS colonization and chronic diseases, complications 
(previous abortion, delivery at <37 weeks gestation, premature birth, 
intrauterine death and endometrtitis), and previous antibiotic intake (p>0.05). 
In conclusion, this study showed high prevalence of GBS colonization among 
pregnant women in Gaza strip. Despite the fact that PCR is well known for its 
high sensitivity, low sensitivity was obtained in this study which may be due to 
the collection methods. Vancomycin was the most effective antibiotic against GBS 
isolates.  
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such as endometritis (Winn, 2007), chorioamnionitis 
(Yancey et al., 1994; Winn, 2007), premature delivery 
and intrauterine death (Tyrrell et al., 2000).  
The incidence of invasive neonatal GBS infection is 
reported to range from 0.5 to 3.0 per 1000 live births, 
with 4%-10% mortality associated with early-onset 
infections (Schrag et al., 2000; Centers for Disease 
Control and Prevention, 2010). Rectovaginal 
colonization occurs in 10 to 30% of pregnant women 
(Dillon et al., 1982; Boyer et al., 1983). GBS colonization 
rate may vary with characteristics such as age, parity, 
socio-economic status, geographic location (Regan et 
al., 1991), presence of sexually transmitted diseases 
(Persson et al., 1981) and sexual behavior (Foxman et 
al., 2007). 
Guidelines from the Centers for Disease Control and 
Prevention (CDC) recommend that all women should be 
screened at 35-37 weeks of gestation and that those 
women found to be colonized with GBS should receive 
intrapartum intravenous antibiotic prophylaxis either 
with penicillin G or ampicillin (CDC, 2010). This was 
shown to be effective in reducing the incidence of early-
onset neonatal GBS infections (Boyer and Gotoff, 1986). 
The standard method for diagnosis of GBS colonization 
comprises culture of combined vaginal and rectal 
samples in a selective enrichment medium, such as Lim 
broth, i.e. Todd-Hewitt broth with colistin and nalidixic 
acid, followed by subculture on sheep blood agar. 
However, this method requires at least 48 h for fully 
GBS identification (Schuchat, 1998; Schrag et al., 
2002a). 
CDC identified various research priorities, including 
‘the development of media with a reliable color 
indicator to signal the presence of GBS to improve 
accuracy of prenatal culture results and facilitate 
prenatal culture processing at clinical laboratories with 
limited technical capacity (Schrag et al., 2002b). It 
includes a novel chromogenic agar, i.e. chromID Strepto 
B (formerly Strepto B ID) agar or ChromAgar, which 
highlights GBS as red colonies after aerobic incubation 
(Tazi et al., 2008). 
Molecular techniques, such as PCR (polymerase chain 
reaction) tests, have become the focus of investigation 
of detection of GBS colonization in pregnant women 
(Wang and Richardson, 1990; Gavino and Wang, 2007) 
because of the relative simplicity and speed. 
There are no previous studies addressing the 
prevalence of GBS among pregnant women in Gaza. In 
this study, we also investigated the antimicrobial 
susceptibility of the GBS isolates.  
2. Materials & Methods: 
Study design: 
A descriptive cross sectional prospective study was 
conducted to determine the prevalence of GBS 
colonization and susceptibility pattern among pregnant 
women attending antenatal clinic of Al Shifa hospital, 
Gaza, Palestine. Four hundreds recto-vaginal swab 
samples were collected from 200 pregnant women at 
35-37 weeks of gestation from Al Shifa hospital (Two 
samples from each pregnant women, one for culture 
and the other for PCR). This screening approach was 
based on universal screening of all pregnant women for 
GBS colonization at 35 to 37 weeks of gestation (CDC, 
2010).  
All participants provided informed consents. Pregnant 
women on any antibiotic treatment and those who 
were not within the range of 35 through 37 weeks of 
gestation, were excluded. The age of the study 
participants ranged from 15 to 45 years with a mean of 
25.1 (±4.7). The study was conducted from May to 
August 2016 in Gaza strip, Palestine  
The necessary approval to conduct the study was 
obtained from Helsinki committee in Gaza strip. All 
participating women were asked to sign a consent form 
after explaining the research nature and objectives. A 
questionnaire was used to collect data with the aim of 
determining possible risk factor associated with 
women who had GBS infections/colonization. A 
structured questionnaire was used and included 
questions about age, education level, medical history of 
patients, the number of births and the number of 
previous miscarriages, materials used for cleaning, and 
other question regarding possible risk factors of GBS 
colonization. The questionnaire was conducted through 
face-to-face interview.  
Collection and culture of specimens: 
Two recto-vaginal swabs were collected from each 
participating pregnant women in their third trimester 
(35-37 weeks of gestation). One of the swab contain 
Amies transport medium for culturing procedure and 
the second one contain 1 ml of phosphate buffer saline 
for PCR analysis. The swabs were labeled properly and 
transported to the microbiology laboratory within two 
hours of collection. 
Recto-vaginal sampling was carried out by rotating a 
swab against the vaginal wall at the mid-portion of the 
vault. Subsequently, the swab was carefully withdrawn 
to prevent contamination with microflora from the 
vulva and introitus and the swab was inserted 1.5 to 2 
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cm beyond the anal sphincter and gently rotated to 
touch the anal crypts (El Aila et al., 2010). 
Direct plating was carried out by inoculating the swab 
that was inoculated in Amies transport medium onto 
chromID Stepto B agar. The ChromAgar plates were 
incubated at 37°C for 18-24 h in aerobic conditions. The 
chromogenic selective medium is supplemented with 
three chromogenic substrates to optimize the 
identification of GBS, which appears red colonies that 




Figure 1   Appearance after 24 h incubation of (A): 
Streptococcus agalactiae (Group B Streptococcus 
(GBS) and (B) Enterococcus faecalis on Strepto B 
ID® chromogenic agar 
 
Identification of the isolates as Streptococcus 
agalactiae: 
The isolates were identified as S. agalactiae by the 
following criteria: colony morphology, cultural 
characteristics, formation of red colonies on 
ChromAgar plates, positive for the CAMP test on blood 
agar, and molecular identification by PCR after 
extraction of DNA from GBS colonies. 
DNA extraction of bacterial isolates: 
DNA was extracted from cultured isolates by alkaline 
lysis as previously described (El Aila et al, 2009). 
Briefly, one bacterial colony was suspended in 20 µl of 
lysis buffer (0.25% sodium dodecyl sulfate, 0.05 N 
NaOH) and heated at 95 °C for 15 min. The cell lysate 
was diluted by 180 µl of distilled water. The cell debris 
was pelted by centrifugation at 16000 xg for 5 min. and 
the supernatants were used for PCR or frozen at -20 °C 
until further use. 
DNA extraction of clinical isolates: 
 DNA extraction from the samples was performed using 
the Genomic DNA Kit according to the manufacturer’s 
instructions. Briefly, 200 μl of transport medium from 
each the rectovaginal swab is placed into 
microcentrifuge tube. 180 μL lysis buffer and 25 μL 
Protenase K solution were added and incubated at 56°C 
for 1-3 hr. Sample tube was vortex and 200 μL lysis 
Buffer G3 were added and incubated at 70°C for 10 min. 
To adjust DNA binding condition, 210 μL of ethanol 
were added. 500 μL wash buffer GW1 and 600 μL wash 
buffer GW2 were used for washing. To elute DNA 100 
μL preheated Elution buffer G are added directly onto 
silica membrane (Bioline, UK). 
Detection of GBS by PCR:  
GBS nucleic acid detection is based on targeting the cfb 
gene, which encodes the CAMP, factor (Ke et al., 2000). 
The PCR reaction mixture contained primers specific 
for group B streptococci. The forward and reverse 
sequences of the primers Are Sag 059 (5´-
TCACCAGCTGTATTAGAAGTA-3´) (369–391) and Sag 
190, (5´-GTTCCCTGAACATTATCTTTGAT-3´) (500–
522). The GBS-specific primers amplify a fragment of 
153 bp (Ke et al., 2000). 
The reactions were performed in 25µl final volumes in 
the presence of 1µM of each primer, 2µl DNA and 1X of 
the GoTaq Green MMX (Promega, USA). The thermal 
cycling program for detection of cfb gene was as 
follows: denaturation at 94°C for 3 minutes, followed 
by 40 cycles of 1 second at 95°C and 30 seconds at 55°C 
for the hybridization step, with a final period of 
extension at 72°C for two minutes. The amplified 
products were resolved on a 2% agarose gel. The 
fragments were stained with ethidium bromide and 
visualized and photographed using gel documentation 
system. A 100bp ladder was run as a molecular weight 
marker. Positive and negative controls were added in 
each run. 
Antibiotic susceptibility testing:  
 GBS isolates were subcultured onto sheep Blood Agar 
plates and incubated aerobically for 24 hours at 37 °C. 
Antimicrobial susceptibility testing (AST) was 
performed according to CLSI guidelines (CLSI, 2010). 
 Sensi-Discs (Liofilchem, Roseto-Italy) of vancomycin 
(30μg), penicillin G (10IU), clindamycin (2μg), 
erythromycin (15μg), and tetracycline (30μg) were 
placed 12 mm apart to detect antimicrobial 
susceptibilities of 42 GBS isolates. 
Data analysis 
The results were tabulated and analyzed using version 
20 of the Statistical Package for the Social Sciences 
(SPSS). Frequencies, cross tabulation, and appropriate 
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statistical tests as Chi-square test and fisher exact test 
were performed. A P-value of less than 0.05 was 
considered significant. 
3. Results: 
Prevalence of GBS using conventional methods: 
A total of 200 pregnant women (from 35-37 weeks of 
gestation) from antenatal clinic of Al shifa hospital- 
Gaza, Palestine participated in this study from May to 
August, 2016. The overall prevalence of GBS 
colonization as determined by chromogenic culture 
was 21%. The prevalence of GBS colonization among 
participants with age less than 25 years was (19%), 
while participants that age more than 25 years was 
(21%). The frequency of GBS colonization among 
different age groups was not statistically significant by 
culture (p> 0.05) (Table 1). 
 
Table 1   Prevalence of GBS colonization in 200 pregnant 
women at 35 - 37 weeks 
Age group 
Culture results p-
value Positive % Negative % 
≤ 25 years 25 19.2 105 81.3 
0.40 > 25 years 17 24.2 53 74.6 
Total 42 21 158 7.9 
 
Identification of Group B Streptococci using PCR: 
Alkaline DNA extraction was done for all 42 GBS 
isolates that were detected by conventional methods 
(Chromagar). The DNA extracts were subjected to PCR. 
Positive and negative control were included in each 
run. All DNA extracts of 42 GBS isolates were positive 
by PCR. This confirm our results by conventional 
method.  
Detection of Group B Streptococci using PCR 
directly from clinical samples: 
Among 200 women included, 42 (21%) were identified 
as GBS positive based upon the culture results of 
rectovaginal swabs. Only 100 rectovaginal samples 
were subjected to PCR analysis. They included the 42 
samples, that were positive by conventional methods, 
and another 58 samples were selected randomly. 
Out of the 42 samples, which were positive by 
conventional methods, only 23 were positive by PCR 
(54%), but 19 (45%) were positive by culture and 
negative by PCR (Figure 2). Of the 58 randomly selected 
samples, seven (12%) were positive using PCR and 
negative by phenotype (culture methods). 
Not all culture-positive samples were also positive with 
the PCR technique therefore resulting in 54% PCR 
sensitivity. Out of 58 culture negative samples for GBS, 
7 were positive with PCR and 51 were negative with 
both methods, which indicate a specificity of 88%. The 
positive and negative predictive value were (76%,72%) 
respectively (Figure 2 & Table 2). 
  
 
Figure 2   A representative result of GBS PCR directly from 
clinical sample 
 
Lane L: 100 bp DNA ladder; lane 1: positive control; 
lanes 2, 3, 5,6 and 7 are tested isolates with positively 
amplified GBS genes; lane 4 is negative control and lane 
8 is a blank. 
 






Positive 23 7 30 
Negative 19 51 70 
Total 42 58 100 
 
Antimicrobial Susceptibilities of GBS: 
Of the 42 examined GBS isolates, 32 (76%) were 
susceptible to vancomycin, 24 isolates (57%) were 
susceptible to penicillin, and 21 (50%) to erythromycin. 
The overall susceptibility of GBS isolates to tetracycline 
were 20 (48%), and to clindamycin, 13 (31%) (Table 
3). Resistance to clindamycin, tetracycline, 
erythromycin, penicillin, and vancomycin was found to 
be 69%, 45%, 43%, 38%, 21% respectively. Of the 
erythromycin-resistant isolates, 18/47 (38%) showed 
cross-resistance to clindamycin. However, tetracycline 
resistant isolates showed 14/48 (29%) cross-
resistance to clindamycin. 
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Table 3   Antibiotic susceptibilities of 42 GBS isolates from 
pregnant women 
No. (%) of isolates 
Agent Susceptible Intermediate Resistant 
Clindamycin 13 (31%) 0 (0%) 29 (69%) 
Erythromycin 21 (50%) 3 (7%) 18 (43%) 
Penicillin 24 (57%) 2 (5%) 16 (38%) 
Tetracycline 20 (48%) 3 (7%) 19 (45%) 
Vancomycin 32 (76%) 1 (2%) 9 (21%) 
 
Risk factors: 
Different variables associated with GBS colonization are 
outlined in Table 4. There was no statistically 
significant difference among groups based on education 
level (university education, level 21% by PCR and 30% 
by culture; secondary school level, 20% by PCR and 
23% by culture and the Preparatory education level, 
22% by PCR and 25% by culture). 
Of women with GBS colonization, those with genital 
tract inflammation were 29% (p=0.59) by PCR, and 
25% (p=0.65) for the culture assay. However, GBS 
colonization and inflammation was not statistically 
significant. Among GBS isolated, 33% were isolated 
from pregnant women had chronic disease by culture 
assay (0% for the PCR assay) (Table 4).  
No statistically significant difference was observed in 
GBS colonization rate and chronic disease (p<0.05). Of 
the pregnant women who had previous antibiotic 
intake, 10 (24%) were positive for GBS by culture and 5 
(17%) by PCR (p <0.05). In addition, no statistically 
significant correlation was observed in GBS 
colonization rate and previous antibiotic intake. 
Out of GBS positive (by culture and PCR), 24% were 
from pregnant women who had complication (Previous 
abortion – delivery at <37weeks gestation- premature 
birth- intrauterine death– endometritis). No 
statistically significant difference was observed in GBS 
colonization rate and chronic disease (p <0.05). 
Overall, no statistically significant association was 
observed for GBS colonization in the study subjects 
with any of the risk factors. 
 





value Positive % Negative % Positive % Negative % 
Education level 
University 7 21 27 79 
0.979 
6 30 14 70 
0.834 Secondary 25 20 97 80 13 23 44 77 
Preparatory 8 22 28 78 6 25 17 75 
Second Wife 
Yes 0 0 8 100 
0.299 
0 0 5 100 
0.297 
No 40 22 145 78 28 30 67 70 
Chronic disease 
Yes 2 33 4 67 
0.557 
0 0 6 100 
0.267 
No 38 20 150 80 28 30 66 70 
Inflammation 
Yes 21 25 62 75 
0.645 
12 29 29 71 
0.589 




40 21 152 79 
0.777 
28 15 164 85 
0.419 
No 2 25 6 75 2 25 6 75 
Using of antibiotic 
Yes 10 24 32 76 
0.832 
5 17 24 83 
0.620 
No 30 20 120 80 23 32 48 68 
Complications 
Yes 11 24 34 76 
0.798 
7 24 22 76 
0.888 
No 28 19 116 81 21 30 50 70 
 
4. Discussion: 
To prevent group B streptococcal disease in neonates, it 
is recommended to screen pregnant women by 
culturing recto-vaginal swabs at 35 to 37 weeks 
gestation and to treat those with positive cultures or to 
treat women with risk factors for disease transmission 
empirically (Daniels et al., 2009). A more rapid and 
sensitive method would be beneficial, and cost-effective 
approach especially in dealing with patients who 
present at term with unknown GBS colonization status 
and preterm labor conditions (Block et al., 2008; CDC, 
2010).  
Prevalence of Group B Streptococci using 
conventional methods: 
Since vaginal and in particular rectal flora contains 
numerous microorganisms, the use of selective culture 
medium is recommended to maximize the isolation of 
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GBS and to avoid the overgrowth of other organisms. In 
this study, a selective chromogenic medium was used, 
which enables the recognition of S. agalactiae as pink to 
red, round and pearly colonies, without the need of 
anaerobic incubation. This medium has excellent 
performance for the GBS prenatal screening in terms of 
nutrient capacity and sensitivity of detection. It is 
capable of detecting all GBS strains, including non ß-
hemolytic strains. Most other bacterial species are 
either inhibited or the colonies produced have a 
different color (e.g. violet, blue, colorless) (Tazi et al., 
2008; Tazi et al., 2009; El Aila et al., 2010).  
In our study, the prevalence rate of GBS among 
pregnant women was 21%. Our results were consistent 
with findings in the developing and developed 
countries as in Blantyre, Malawi, (16.5%) (Dzowela et 
al., 2005), in Egypt, (17.89%) (Elbaradie et al., 2009), in 
Kuwait (16.4%) (Al-Sweih et al., 2004), in Zimbabwe, 
(21%) (Mavenyengwa et al., 2010), in Dare salaam, 
Tanzania, (23%) (Joachim et al., 2009), in Belgium 
(22%) (El Aila et al., 2010), in Netherlands (21%) 
(Valkenburg-van den Berg et al., 2006), in Germany 
(23%) (Von Both et al., 2008), and in Sweden (25.4%) 
(Håkansson et al., 2008). However, the finding of this 
study is higher when compared to colonization rate 
from other countries like Mozambique which reported 
colonization rate of 1.8% (De Steenwinkel et al., 2008), 
4.8% in Iran (Shirazi et al., 2014), 7.5% in the 
Philippines (Whitney et al., 2004) and 8% in France 
(van der Mee-Marquet et al., 2006). Lower GBS 
colonization rate have been found in some 
Mediterranean countries, e.g. 6.6% in Greece (Tsolia et 
al., 2003), 9.2% in Turkey (Eren et al., 2005) and 12.3% 
in Israel (Marchaim et al., 2003). But findings from 
different studies conducted in Trinidad found a higher 
colonization rate of pregnant women with GBS, 32.9% 
(Orrett, 2003).  
The different prevalence rates may be explained by 
gestational age at culturing, differences in culture sites 
and culture techniques, a change of prevalence with 
time, or real differences of prevalence in different 
populations or ethnic groups (Valkenburg-van den Berg 
et al., 2006). Personal hygiene, the extensive use of 
antiseptics/antibiotics, standard of living, and other 
socioeconomic factors may contribute to the variation 
in colonization rates. 
Numerous studies have documented that the accuracy 
of prenatal screening cultures in identifying 
intrapartum colonization status can be enhanced by 
careful attention to the timing of cultures, the anatomic 
sites swabbed and the laboratory procedures used for 
culture and detection of the organisms (Schrag et al., 
2002a). Swabbing both the vagina and the rectum 
substantially increases the yield compared with 
sampling only the cervix or sampling the vagina 
without swabbing the rectum. There are several studies 
that find rectovaginal sampling is more appropriate 
than vaginal sampling only in detecting GBS (CDC, 
2002; Diaz & Nieves, 2008; El Aila et al., 2010). 
Detection of GBS carriage rate by PCR: 
Out of 100 rectovaginal samples were subjected to PCR, 
30 were positive for GBS. 23 of them were culture 
positive and PCR positive whereas the remaining seven 
samples were PCR positive and culture negative. 
Nineteen of the culture-positive recto-vaginal samples 
were PCR negative when DNA extracted directly from 
the rectovaginal swab. Inappropriate sample collection 
may explain the false negative PCR results. Also, it can 
be explained by the fact that we used two different 
swabs collected from each pregnant women (one for 
PCR and one for culture). The collection of these swabs 
although at the same time may not represent identical 
microbial content and may indicate poor specimen 
collection. Other studies performed culture and PCR 
from the same swab collected (Rallu et al., 2006; El Aila 
et al., 2011).  
In contrast to our results, several studies have reported 
an increased GBS detection rates by PCR diagnostic 
tests over standard culture method (Espy et al.,2000; 
Sloan et al., 2002; Shabayek et al., 2010; Bakhtiari et al., 
2012). El Aila et al. (2011) reported that QPCR directly 
on the sample significantly has increased the number of 
women found to be GBS-positive (27%) compared to 
culture (22%).  
Considering culture as a gold standard, sensitivity, 
specificity, positive predictive value and negative 
predictive value of PCR was 54%, 87.9%, 76%, 72%, 
respectively. 
Low sensitivity of PCR was reported in our study which 
is consistent with PCR results obtained by Chan et al, 
who reported that PCR sensitivity was lower than that 
of standard conventional culture. The sensitivity and 
specificity of the PCR assay were 45% and 99%, 
respectively (Chan et al., 2006). He claimed that the 
problem with their test was at the sample preparation 
stage and the swabs they used for collection contain 
charcoal in the transport medium, which has been 
shown to reduce the sensitivity of PCR (Cloud et al., 
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2002; Chan et al., 2006). Other studies reported the rate 
of sensitivity and specificity of PCR was (100%, 
86.88%) respectively (de-paris et al., 2011). Davies et 
al. (2004) reported the sensitivity, specificity, positive 
predictive value and negative predictive value of PCR 
was 94%, 96%, 84%, 99% respectively. Bergeron et al. 
(2000), in their study, had a sensitivity of 97%, 
specificity of 100% and positive and negative 
predictive values of 100% and 99%, respectively.  
Out of 58 samples were negative for GBS detection by 
culture, seven (12%) were positive by PCR. False 
negative culture results may be explained by the 
presence of antagonistic microorganisms, such as 
enterococci, which may inhibit the growth of GBS on 
the selective media (Dunne and Holland-Staley, 1998). 
In addition, antibiotics and feminine hygiene products 
have been shown to inhibit the growth of GBS and 
scanty colonization, which would be difficult to obtain 
in culture (Rallu et al., 2006; Werneke et al., 2009). 
Furthermore, inappropriate storage and transport 
conditions of the samples could give false-negative 
culture results (Rosa-Fraile et al., 2001). 
Antimicrobial Susceptibilities of GBS: 
The prophylaxis currently recommended for 
prevention of neonatal disease is the intrapartum use of 
antibiotics only in women known to be colonized by 
GBS. The susceptibility testing revealed that 76% of 
GBS isolates were susceptible to vancomycin, 57% of 
the isolates were susceptible to penicillin. Such findings 
coincides with that obtained by Moyo et al. (2001); 
Hsueh et al. (2001); Banno et al. (2014); Gaudreau et al. 
(2010); Kimura et al. (2008) and Longtin et al. (2011), 
who reported reduced susceptibilities to penicillin. Our 
results were different with Brandon and Dowzicky 
(2013) who found that GBS isolates were 100% 
susceptible to both penicillin and vancomycin. Due to 
the widespread use of the antibiotic and the misuse of 
antibiotics, antibiotic-resistant organisms are in the 
rise. As indicated in the present study, 43% of GBS 
isolates were resistant to erythromycin which was 
higher than obtained by Joachim et al. (2009), and 
Azavedo et al. (2001), (29%) reported by Manning et al. 
(2004) and (11.8%) in Lebanon (Hannoun et al., 2009). 
Azavedo et al., (2001) and Hannoun et al., (2009) have 
reported resistance rate >80% for tetracycline which 
was higher than the findings reported in the present 
study (45%). However the prevalence of clindamycin 
resistant isolates (69%) in our study, was higher than 
the findings reported by Andrews et al. (2000).  
Verani et al. (2010) recommended the use of 
vancomycin for GBS-colonized mothers with a high risk 
of anaphylaxis to penicillin and if the isolate is resistant 
to clindamycin. In this study, we found that 21% of the 
isolates were resistance to vancomycin. This finding is 
comparable to those reported in other studies (Fashina, 
2008; Onipede et al., 2012). CDC recommended 
vancomycin as alternative for pregnant women who are 
allergic to penicillin and clindamycin resistant isolates 
(CDC, 2010). 
Penicillin is the first-choice of drug, while ampicillin is 
an alternative and, in cases of history of allergy (rash or 
a history of difficulty in breathing) to penicillin and at 
high risk for anaphylaxis, clindamycin and 
erythromycin were recommended (Verani et al., 2010). 
In GBS-colonized mothers with allergy and low risk of 
anaphylaxis to penicillin, the use of cefazolin is 
recommended. In those with a high risk of anaphylaxis 
to penicillin and if the isolate is resistant to 
clindamycin, vancomycin is recommended (Verani et 
al., 2010; Frohlicher et al., 2014).  
Antibiotic resistance amongst GBS is considered an 
increasing problem so that it was recommended to test 
the susceptibility of other antibiotics than those 
recommended as part to established control measures 
and that could be used as alternative choices for 
prophylaxis or treatment of GBS infection (Quiroga et 
al., 2008; Verani et al., 2010). 
Risk factors for GBS carriage pregnant women: 
Knowledge about risk factors contributing to GBS 
colonization in pregnant women is relevant to 
minimize the morbidity, mortality associated with 
maternal and neonatal GBS infections. In the present 
study, no statistically significant association was 
observed for GBS colonization in the study subjects 
with any of socio-demographic characteristics as 
outlined in (Table 4). Similar findings have been 
reported in studies conducted by Zusman et al. (2006) 
and Costa et al. (2008). 
In the present study, history of spontaneous abortion 
did not influence GBS colonization in pregnant women. 
Similar findings have been reported in studies 
conducted by Joachim et al. (2009). In contrast with our 
results, McDonald & Chambers (2000) demonstrated an 
association between the presence of GBS and 
spontaneous abortions.  
Garland et al. (2000) did not detect an association 
between GBS colonization and preterm labor and 
premature rupture of the membranes. These results are 
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similar to those observed in our study. Although some 
investigators such as Feikin et al. (2001), who found 
that women with preterm delivery have a significantly 
higher frequency of GBS colonization. 
5. Conclusion: 
Our results showed high prevalence of GBS colonization 
among pregnant women in Gaza Strip, Palestine. This 
study was the first to be done in Gaza, so to obtain more 
information, we recommend screening for GBS in all 
pregnant women attending antenatal care at 35-37 
weeks of gestation and a close observation for all their 
newborns. This could aid clinicians to rapidly 
determine pregnant women colonized with GBS so as to 
take necessary steps of treatment.  
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 اجالكتيا كوككس الستربتو بكتيريا انتشار مدى دراسة
 غزة قطاع في الحوامل بين
اجالكتيا سببا مهما لاللتهابات التي تحدث لألطفال حديثي الوالدة في جميع أنحاء تعتبر بكتيريا ستربتو كوككس 
العالم. وقد كان الهدف من هذه الدراسة تقييم مدى انتشار هذا النوع من البكتيريا بين النساء الحوامل في قطاع 
 غزة.
وقد تم عبمستشفى الشفاء مسحة شرجية مهبلية من النساء الحوامل 200تم جمع  زل وتشخيص هذا الميكروب .
(. حيث تم (CDCبالطرق الميكروبيولوجية القياسية وفقا لتوصيات مركز السيطرة على األمراض والوقاية 
استخدام أوساط بيئية انتقائية مثل كروموجينيك أجار للتعرف على الميكروب. كذلك تم التشخيص باستخدام تفاعل 
 الحساسية للعديد من المضادات الحيوية.البلمرة المتسلسل وتم ايضا إجراء اختبار 
وقد  ،%21ريقة الزراعة على الكروم أجارأظهرت النتائج بأن نسبة انتشار البكتيريا بين الحوامل باستخدام ط
هي  تفاعل البلمرة المتسلسلكانت الحساسية والنوعية والقيمة التنبؤية اإليجابية والقيمة التنبؤية السلبية لفحص 
وقد كانت نسبة استجابة هذا الميكروب للمضادات الحيوية التالية:  .% على التوالي%72، 76 ،%88%، 54
٪، 50٪، 57٪، 76الفانكومايسين، البنسلين، االريثروميسين، التتراسيكلين والكلينداميسين على الشكل التالي 
ربتو كوككس اجالكتيا وعوامل ٪. كما أنه لم يكن هناك ارتباط ذو داللة إحصائية بين وجود ميكروب ست31٪ و48
(، موت الجنين داخل الرحم -جنين غير كامل النضوج -والدة مبكرةاألمراض المزمنة، والمضاعفات )الخطورة مثل 
 (.P>0.05وتناول المضادات الحيوية سابقا )
 بين النساء الحوامل في قطاع غزة.  ستربتو كوككس اجالكتيادللت النتائج السابقة على ارتفاع نسبة ميكروب 
نه قد تم الحصول على نسبة إمعروف بحساسيته العالية، ف تفاعل البلمرة المتسلسلوأنه على الرغم من أن فحص 
منخفضة في هذه الدراسة. وقد أظهر المضاد الحيوي الفانكومايسين أعلى معدل فاعلية مقارنة بالمضادات الحيوية 
 ستربتو كوككس اجالكتياهذه الدراسة بعمل فحوصات بشكل روتيني للكشف عن ميكروب  األخرى. ونوصي من خالل
 .العيادات والمستشفيات الفلسطينيةللنساء الحوامل في 
 كلمات مفتاحية:
 ،اجالكتيا كوككس ستربتو
 ،المتسلسل البلمرة تفاعل
 ،الحمل
 ،المزرعة
 .غزة قطاع
